Health and Fitness Health and Fitness
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012
Mon, August 20, 2012
[ Mon, Aug 20th 2012 ] - Market Wire
Watson Launches Generic Xopenex
Sat, August 18, 2012
Fri, August 17, 2012

Durata Therapeutics to Present at BioCentury NewsMakers Conference


//health-fitness.news-articles.net/content/2012/ .. present-at-biocentury-newsmakers-conference.html
Published in Health and Fitness on Tuesday, August 28th 2012 at 5:02 GMT by Market Wire   Print publication without navigation


MORRISTOWN, N.J.--([ ])--Durata Therapeutics (NASDAQ: DRTX) today announced that Paul Edick, Chief Executive Officer, will present an overview of the company at the 2012 BioCentury NewsMakers in the Biotech Industry conference.

The Durata presentation will take place at the Millennium Broadway Hotel in New York, NY on Friday, September 7, 2012 at 9:00 a.m. ET. [A live webcast will be available at [ http://www.duratatherapeutics.com ].]

About Durata Therapeutics

Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. Durata is currently enrolling and dosing patients in two global Phase 3 clinical trials with its lead product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections, or abSSSI.

Forward-looking statements

Any statements in this press release about Durataas future expectations, plans and prospects constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Durata anticipates that subsequent events and developments will cause its views to change. However, while Durata may elect to update these forward-looking statements at some point in the future, Durata specifically disclaims any obligation to do so.


Publication Contributing Sources